Anti-cementoblastoma-derived protein antibody partially inhibits mineralization on a cementoblastic cell line.
The effect of human anti-cementoblastoma-derived protein antibody during cementogenesis in vitro was investigated by using human cementoblastoma-derived cells. Cultures treated with 5 microg/ml of CP antibody from day 1 to day 15 revealed a significant decrease in alkaline phosphatase activity (ALP) 40% (p < 0.005), 44% (p < 0.001), 49% (p < 0.1), and 45% (p < 0.02) at 9, 11, 13, and 15 days, respectively. Immunoexpression of osteopontin revealed that in cultures treated with anti-CP antibody, the positive number of cementoblastoma cells was reduced by 87, 83, 69, and 52% at 5, 7, 9, and 11 days, respectively. Bone sialoprotein immunoexpression showed a decrease in positive cells of 82, 51, 60, 80, 83, and 87% at 5, 7, 9, 11, 13, and 15 days, respectively, as compared to controls. The Ca/P ratio of the mineral-like tissue deposited in vitro by cementoblastoma cells revealed that control cultures had a Ca/P ratio of 1.45 and 1.61 at 5 and 15 days, whereas experimental cultures revealed a Ca/P ratio of 0.50 and 0.79 at 5 and 15 days, respectively. Electron diffraction patterns showed inner double rings representing D-spacing that were consistent with those of hydroxyapatite in both control and experimental cultures. Examination of the crystallinity with high resolution transmission electron microscopy showed homogeneous and preferential spatial arrangement of hydroxyapatite crystallites in control and experimental cultures at 15 days. Atomic force microscopy images of control cultures at 5 and 15 days revealed small granular particles and grain agglomeration that favored the formation of crystalline plaques with a lamellar-like pattern of the mineral-like tissue. Experimental cultures at 5 and 15 days showed tiny and homogeneous granular morphology. The agglomerates maintained spherical morphology without organization of needle-like crystals to form plaque-like structures. Based on these findings, it is hypothesized that cementoblastoma-derived protein may be associated to crystal growth, compositional and morphological features during the mineralization process of cementum in vitro.
Alvarez Pérez
Marco Antonio
MA
Laboratorio de Biología Celular y Molecular, Facultad de Odontología, UNAM, Mexico.
Pitaru
Sandu
S
Alvarez Fregoso
Octavio
O
Reyes Gasga
José
J
Arzate
Higinio
H
D000469:Alkaline Phosphatase / Q000096:biosynthesis; D000906:Antibodies / Q000737:chemistry*; D015153:Blotting, Western; D002455:Cell Division; D045744:Cell Line, Tumor; D002470:Cell Survival; D002485:Cementoma / Q000276:immunology / Q000378:metabolism*; D003739:Dental Cementum / Q000276:immunology* / Q000378:metabolism*; D004583:Electrons; D006801:Humans; D018625:Microscopy, Atomic Force; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D008856:Microscopy, Fluorescence; D053495:Osteopontin; D012795:Sialoglycoproteins / Q000096:biosynthesis; D013997:Time Factors; D014961:X-Ray Diffraction
D000906:Antibodies; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin; D000469:Alkaline Phosphatase